Recent News

January 11, 2022

Catalyst OrthoScience Names Carl O’Connell as President and CEO

December 13, 2021

Archer™ Shoulder Systems Presented, Catalyst Orthoscience Showcasing Innovative Products at Upcoming Orthopedic Events

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
October 6, 2021

Catalyst Orthoscience Announces $12.3 Million Oversubscribed Financing round to Fuel Company Momentum in Shoulder Arthroplasty

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
August 31, 2021

Catalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOS

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
August 24, 2021

Catalyst OrthoScience Introduces Archer™ 3D Targeting Imaging Software For Preoperative Planning

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
May 5, 2021

Catalyst OrthoScience Announces First Surgeries Using Archer™ R1 Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
April 28, 2021

Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
March 17, 2021

Catalyst OrthoScience Receives FDA 510(k) Clearance Of Its Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
February 17, 2021

Newly Published Study With The Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results In Adult Arthroplasty Patients Of All Ages At 2-3 Year Follow-Up

Published peer reviewed study show significant improvements in motion and patient-reported measures in adult shoulder replacement patients of all ages.
January 27, 2021

Catalyst In The News: Hand and Upper Limb Orthopedic Surgeon Dr. Badia Says Partial Shoulder Reconstruction Option for More Patients and Ideal for Outpatient Surgery; Offers Tips